Average Co-Inventor Count = 7.94
ph-index = 15
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Agensys, Inc. (33 from 196 patents)
2. Amgen Fremont Inc. (10 from 78 patents)
3. Seattle Genetics, Inc. (4 from 132 patents)
4. Seagen Inc. (3 from 64 patents)
5. Astrazeneca Ab (2 from 1,500 patents)
6. Abgenix, Inc. (2 from 32 patents)
7. Imaginab, Inc. (2 from 10 patents)
49 patents:
1. 11559582 - Antibody drug conjugates (ADC) that bind to 191P4D12 proteins
2. 11492411 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
3. 11401347 - Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
4. 11266745 - Extension sequences for diabodies
5. 11254744 - Antigen binding constructs to target molecules
6. 10894090 - Antibody drug conjugates (ADC) that bind to 191P4D12 proteins
7. RE48389 - Antibody drug conjugates (ADC) that bind to 191P4D12 proteins
8. 10597463 - Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
9. 10508153 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
10. 10118968 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
11. 9962454 - Antibody drug conjugates (ADC) that bind to 191P4D12 proteins
12. 9617346 - Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
13. 9314538 - Nucleic acid molecules encoding antibody drug conjugates (ADC) that bind to 191P4D12 proteins
14. 9308278 - Antibody drug conjugates (ADC) that bind to 161P2F10B proteins
15. 9096672 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof